DNR and AraC Combined to Fractionated Mylotarg® in Patients With First Relapse of AML

NCT02182596 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Mylotarg

Sponsor

Acute Leukemia French Association